Nasdaq or NYSE related Health Care sector Top Companies List by Market Cap as of January 2024
Nasdaq or NYSE listed Health Care sector Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Health Care sector Largest Companies List by Market Cap as of Jan-05-2024
-
World Rank (Jan-05-2024)3,968Market Cap (Jan-05-2024)3.404 Billion USDWorld Rank (Jul-30-2023)4,196Market Cap (Jul-30-2023)3.164 Billion USDWorld Rank (Dec-25-2022)14,035Market Cap (Dec-25-2022)0.390 Billion USDCompany ProfileMOONLAKE IMMUNOTHERAPEUTICS is a clinical stage biopharmaceutical company with the novel investigational Nanobody for the treatment of inflammation to revolutionize outcomes for patients. The headquarters is in Switzerland.Company Website
-
iRhythm Technologies
World Rank (Jan-05-2024)4,271Market Cap (Jan-05-2024)3.102 Billion USDWorld Rank (Jul-30-2023)4,219Market Cap (Jul-30-2023)3.145 Billion USDWorld Rank (Dec-25-2022)4,228Market Cap (Dec-25-2022)2.867 Billion USDWorld Rank (Jan-07-2022)4,850Market Cap (Jan-07-2022)3.00 Billion USDAnnual Revenue in USD410 Million USDAnnual Net Income in USD-116 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileiRhythm is a Clinical Digital Healthcare company focused on complete ambulatory cardiac monitoring solution. The headquarters is in USA.
Company Website -
Indivior
World Rank (Jan-05-2024)5,511Market Cap (Jan-05-2024)2.101 Billion USDWorld Rank (Jul-30-2023)4,222Market Cap (Jul-30-2023)3.140 Billion USDWorld Rank (Dec-25-2022)3,930Market Cap (Dec-25-2022)3.174 Billion USDWorld Rank (Jan-07-2022)5,892Market Cap (Jan-07-2022)2.21 Billion USDAnnual Revenue in USD901 Million USDAnnual Net Income in USD-53 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileIndivior is a global pharmaceutical company working to help change patients lives by pioneering life transforming treatment for substance use disorders and other serious mental illnesses. The company annual revenue is 647 million USD and total assets are 1,531 million USD as on 2020. The headquarters is in UK.
-
LivaNova
World Rank (Jan-05-2024)4,732Market Cap (Jan-05-2024)2.683 Billion USDWorld Rank (Jul-30-2023)4,247Market Cap (Jul-30-2023)3.108 Billion USDWorld Rank (Dec-25-2022)4,217Market Cap (Dec-25-2022)2.874 Billion USDWorld Rank (Jan-07-2022)3,621Market Cap (Jan-07-2022)4.40 Billion USDAnnual Revenue in USD1,035 Million USDAnnual Net Income in USD-135 Million USDAnnual Results for Period EndingDec-2021 ending yearCompany ProfileLivaNova is a Medical Technology company. The company products and therapies are neuromodulation, resources and cardiovascular. It offers a diverse product portfolio with a differentiated pipeline and reach is broad with a presence in more than 100 countries and approximately 4,000 employees. The headquarters is in UK.
Company Website -
Patterson Companies
World Rank (Jan-05-2024)4,723Market Cap (Jan-05-2024)2.689 Billion USDWorld Rank (Jul-30-2023)4,254Market Cap (Jul-30-2023)3.101 Billion USDWorld Rank (Dec-25-2022)4,415Market Cap (Dec-25-2022)2.712 Billion USDWorld Rank (Jan-07-2022)5,020Market Cap (Jan-07-2022)2.86 Billion USDAnnual Revenue in USD6,499 Million USDAnnual Net Income in USD203 Million USDAnnual Results for Period EndingApr-2022 ending yearCompany ProfilePatterson Companies has expertise in animal healthcare and human dentalcare solutions. It is also holding various leadership positions in sales, marketing, operations, national accounts and business development. The headquarters is in USA.
Facts About CompanyPatterson Companies Annual Total Revenue for year ending Apr-2023 was 6,471 million USD and and Net Income for year ending Apr-2023 was 207 million USD.
Patterson Companies Annual Total Revenue for year ending Apr-2023 was 6,499 million USD and and Net Income for year ending Apr-2023 was 203 million USD.
As on 2022, Patterson Companies has 6,500 employees.
As of April-2021, they had approximately 7,800 full-time employees
Company Website -
Axonics Modulation Technologies
World Rank (Jan-05-2024)4,441Market Cap (Jan-05-2024)2.941 Billion USDWorld Rank (Jul-30-2023)4,293Market Cap (Jul-30-2023)3.066 Billion USDWorld Rank (Dec-25-2022)3,975Market Cap (Dec-25-2022)3.114 Billion USDWorld Rank (Jan-07-2022)5,431Market Cap (Jan-07-2022)2.53 Billion USDAnnual Revenue in USD273 Million USDAnnual Net Income in USD-60 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileAxonics Modulation Technologies is a Medical Technology company. The company annual net revenue is 15.2 million USD and 302 employees as on 2019. The headquarters is in USA.
As of December 2019, they had 302 employees.
Company Website -
Azenta Inc.
World Rank (Jan-05-2024)3,891Market Cap (Jan-05-2024)3.497 Billion USDWorld Rank (Jul-30-2023)4,297Market Cap (Jul-30-2023)3.060 Billion USDWorld Rank (Dec-25-2022)3,235Market Cap (Dec-25-2022)4.036 Billion USDCompany ProfileAZENTA, INC. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. Headquarters is in USA.
The company operates through two reportable segments.
- Life Sciences Products
- Life Sciences Services.
Company Website -
Ultragenyx Pharmaceutical
World Rank (Jan-05-2024)3,549Market Cap (Jan-05-2024)3.941 Billion USDWorld Rank (Jul-30-2023)4,303Market Cap (Jul-30-2023)3.053 Billion USDWorld Rank (Dec-25-2022)4,035Market Cap (Dec-25-2022)3.051 Billion USDWorld Rank (Jan-07-2022)3,267Market Cap (Jan-07-2022)5.03 Billion USDAnnual Revenue in USD363 Million USDAnnual Net Income in USD-707 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileUltragenyx Pharmaceutical is a Clinical Stage Biopharmaceutical company. It committed to bringing to patients novel products for the treatment of rare and ultra rare diseases with a focus on serious debilitating genetic diseases. The company portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for which there are no approved therapies. The headquarters is in USA.
Company Website -
Integer Holdings Corporation
World Rank (Jan-05-2024)4,090Market Cap (Jan-05-2024)3.285 Billion USDWorld Rank (Jul-30-2023)4,304Market Cap (Jul-30-2023)3.053 Billion USDWorld Rank (Dec-25-2022)5,048Market Cap (Dec-25-2022)2.250 Billion USDWorld Rank (Jan-07-2022)5,275Market Cap (Jan-07-2022)2.66 Billion USDAnnual Revenue in USD1,376 Million USDAnnual Net Income in USD66 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileInteger Holdings Corporation is a Medical Device Manufacturing and Design company. The company provides innovative, high-quality technologies and manufacturing to Medical Device OEM’s to enhance the lives of patients worldwide and serving the cardiac, neuromodulation, vascular and portable medical markets. The company products are batteries, capacitors, catheters, class III medical device systems, combined devices, guidewires, introducers, IPG components, lead components, steerable catheters, sheaths and delivery systems, stents and unfiltered and filtered feedthroughs.Company Website -
Immunocore Holdings PLC
World Rank (Jan-05-2024)4,182Market Cap (Jan-05-2024)3.200 Billion USDWorld Rank (Jul-30-2023)4,317Market Cap (Jul-30-2023)3.041 Billion USDWorld Rank (Dec-25-2022)4,355Market Cap (Dec-25-2022)2.769 Billion USDWorld Rank (Jan-07-2022)8,234Market Cap (Jan-07-2022)1.26 Billion USDAnnual Revenue in USD31 Million USDAnnual Net Income in USD-154 Million USDAnnual Results for Period EndingDec-2021 ending yearCompany ProfileImmunocore is a pioneering, clinical-stage T cell receptor biotechnology company working to develop and commercialize a new generation of transformative medicines to address unmet needs in cancer, infection and autoimmune disease. Headquarters is in UK.
Company Website